Join
Live feed
·
PRReleasevia Quantisnow
Tempest Therapeutics Inc. logo

Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

ByQuantisnow·Wall Street's wire, on your screen.
TPST· Tempest Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TPST (Tempest Therapeutics Inc.) and more on Quantisnow.